chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low grade fever; Body ache/ pains; Headache; Eyes became swollen and very sore to touch; Eyes became swollen and very sore to touch; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 8727) via an unspecified route of administration in the left arm on 28Apr2021 at 10:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to mollusks and possibly latex (could not use latex gloves as the skin would react with rash). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0153) via an unspecified route of administration in the left arm on 10Apr2021 at 13:45 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. On 29Apr2021 at 14:00 (about 27 hours after the second dose), the patient experienced low grade fever, body ache, pains, headache, eyes became swollen and were very sore to the touch. The patient was breathing fine. At the time of reporting, 45 hours after the second dose, eyes were still swollen. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with over-the-counter (OTC) diphenhydramine hydrochloride (BENADRYL). The clinical outcome of the events low grade fever, body ache/ pains, headache, eyes became swollen and very sore to touch were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
From the time of my 2nd dose vaccination I was gradually losing weight (estimated 1 pound/month) and my blood sugar was extremely high. I was taking Metformin 1000 mg 2x/day before then when my blood sugar spiked my doctor increased it to 2000 mg 2x/day. Up to this day 02/02/2022 I am still experiencing the same symptoms.
reaction including fever 103 & 6 to 8cm area of cellulitis w/edema @ the site;
Tremors 2hr p/vax then limp & fever 102ax; pt referred to MD office temp 101.5R
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not provided).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The reporter had experienced headaches after she got home from the hospital that Friday the 26th, and the 27th and 28th. For two solid days, it was really unusual, unlike any headaches she had before. It was not severe and she did not need Advil (case MOD-2021-079714). The reporter mentioned that her daughter reported something similar after the Moderna shot. Concomitant drugs were not reported. Treatment information was not provided.
Allergic reaction to vaccine consisting of erythematous area measuring 15 cm, very pruritic of (L) thigh. No fever. No tenderness.
I was having pain in my stomach and stabbing pains in my back. After about 2 and a half weeks, the pain started to get worse and was keeping me up at night, so I called my doctor. I went to see the doctor on February 28, 2023. He recognized the symptoms as I had them about 10 years ago. He prescribed omeprazole 50mg and sucralfate to treat the symptoms. Due to having Helicobacter Pylori previously, they took a stool sample yesterday. My symptoms are stable but about the same in intensity every now and then.
Chills, headache, dizziness, short of breath, muscle ache, injection site pain
Lump injection site; Hard injection site; Itchy injection site; Redness injection site; Swollen injection site; Pain injection site; tired; nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site) and INJECTION SITE SWELLING (Swollen injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site), INJECTION SITE SWELLING (Swollen injection site), INJECTION SITE PAIN (Pain injection site), FATIGUE (tired) and NAUSEA (nausea). At the time of the report, INJECTION SITE MASS (Lump injection site), INJECTION SITE INDURATION (Hard injection site), INJECTION SITE PRURITUS (Itchy injection site), INJECTION SITE ERYTHEMA (Redness injection site), INJECTION SITE SWELLING (Swollen injection site), INJECTION SITE PAIN (Pain injection site), FATIGUE (tired) and NAUSEA (nausea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Outcome for the all the events has been updated from unknown to recovered and patient declined further follow-up
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No information regarding the patient's medical history or concurrent conditions was provided. On 20-JUN-2016, the patient was vaccinated with an improperly stored dose of PROQUAD injection (lot# M001152, expiry date 05-JUL-2017; dose and route of administration were not reported). There were no concomitant therapies reported. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Pt had dystonic reaction s/p influenza (second dose) and H1N1 flu vaccine delivered at Pt's PCP's office today at 0930am. Pt started having dystonic reactions at 1530, presented to emergency dept for c/o of uncontrolled hand wringing and restless movements of both hands.
Got singles, has Shingrix shots/suspected vaccination failure; got Covid in Dec after 3rd Pfizer; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a 55-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included ELASOMERAN (COVID 19 VACCINE MODERNA) for prophylaxis and TOZINAMERAN (COVID-19 VACCINE PFIZER) for prophylaxis.   The patient's past medical history included shingles (in 2011). Previously administered products included Pfizer Covid-19 vaccine (received 2 dose of Pfizer on an unknown date).   On an unknown date, the patient received Shingrix. In May 2022, the patient received the 4th dose of COVID 19 VACCINE MODERNA. On an unknown date, the patient received the 3rd dose of COVID-19 VACCINE PFIZER. In May 2022, more than a year after receiving Shingrix, the patient experienced shingles. On an unknown date, the patient experienced vaccination failure (serious criteria medically significant) and covid-19. On an unknown date, the outcome of the vaccination failure, shingles and covid-19 were unknown.   It was unknown if the reporter considered the vaccination failure, shingles and covid-19 to be related to Shingrix.     Additional Information: receipt date: 29-May-2022 Reporter's comment: The case was received from the patient via social media interactive digital media. The patient had received 3 Pfizer with negative effects. The patient had Shingrix shots and 2 weeks before the reporting day, the patient got shingles right after the 4th shot of Covid vaccine (Moderna). Less than 2 years after the Shingrix shots and unknown after 3rd dose of Pfizer, the patient got Covid in December. It unknown if the reporter considered the Covid-19 to be related to Covid-19 Vaccine Pfizer. It unknown if the reporter considered the vaccination failure, shingles to be related to Moderna Covid-19.  Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding laboratory test confirming shingles were unknown at the time of reporting. Follow-up could not be possible as no contact details were available.
Severe lethargy after receiving the shot.  Constant sleepiness and malaise, nausea, confusion, loss of appetite, dizziness,  Blood vessels/clots formed in her eyes.  Acute renal failure and eventually death on March 18, 2021.
The same day patient had her vaccine she had a 2-3 minute seizure. She has since had about 50 seizures that we know of. She is being treated by a neurologist and is on anti-seizure medications.
Patient had previously received the Pfizer vaccine at another location. No significant symptoms or problems were reported.
Loss of taste, fatigue, no energy, loss of hair, problems with retaining fluids.
i had menstrual spotting for four hours in the middle of my cycle. spotting was at day 15 of my cycle
Small rash at the site; the site of injection is incredibly itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (the site of injection is incredibly itchy) and VACCINATION SITE RASH (Small rash at the site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (the site of injection is incredibly itchy). On 07-Feb-2021, the patient experienced VACCINATION SITE RASH (Small rash at the site). At the time of the report, VACCINATION SITE PRURITUS (the site of injection is incredibly itchy) and VACCINATION SITE RASH (Small rash at the site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Information has been received from a consumer concerning her daughter with no pertinent medical history or drug allergies who on 01-MAR-2001 and 10-AUG-2005 was vaccinated with her first and second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot# 634420/0012L, 647106/0483R) (HSA). Concomitant vaccination administered on 01-MAR-2001 included the third dose of hepatitis B virus vaccine rHBsAg (MSD) (lot# 638081/1667X). Concomitant vaccinations administered on 10-AUG-2005 included the fifth dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid and the fourth dose of inactivated poliovirus vaccine and the fourth dose of inactivated poliovirus vaccine (unspecified) (unspecified). On 29-MAR-2008 the patient experienced measles. The patient was taken to the emergency room but was not hospitalized. No labs or diagnostic studies were performed. Therapy with measles-mumps-rubella vaccine was discontinued. The patient was noted to be recovering. There was no product quality complaint. No further information is available.
pt recvd vax;exp pain & numbness in shoulder down to fingers; subsequently,through a series of complications,pt reportedly devel reflex sympathetic dystrophy, which has required surgical repair;
Patient had syncopal episode when ambulating away from vaccination area. Pt had assisted fall to ground. Pt assessed by nurse and md. Vitals checked, hypotensive and bradycardic. Pt regained consciousness in less than 30 seconds. Vitals monitored. Pt given po fluids. Pt complained of nausea and was treated with PO OTD zofran.  Pt reassessed by md. Pt refused all other medical care. pt ambulated out of clinic with steady gait approx 1 hour after event.
Rash Primarily on arm where I got the shot and patches on other part sod the body
Exacerbation of asthma, mother reports "night tremors", lack of appetite, mother thought that a diagnosis of pneumonia was made; prophylactic antibiotics provided. Entire went followed inadvertent administration of seasonal inactivated H1N1 vaccine 6 days apart.
Severe moving arm from shoulder to wrist. Just hang. Had to hold up with other arm. Couldn't dress myself. Need help still a little hard certain way to move.
HPV vaccine given 2/15/07. PT called office 2/20/07 with reports of "breaking out from vaccine". States on 2/18 she had hives on waist up, dry and flaky. Only "pain and pimple" at injection site (R arm). Pt denied any other changes in detergents, soap, food, perfume, lotion, etc. Pt told to take Benadryl.
Tuesday night, my eyes got real weird and woke the next day I severe double vision. I was prescribed steroids. and infusions to help. I was diagnosed with CMF Demyelinating Disease (HCC).
Patient reported rash and itchiness on her chest and face that aggravated her eczema. She reported few tiny blisters on her face with pus in them. She took allegra and Benadryl to relieve her symptoms. Her symptoms is slowly getting better, but the itchiness remains. It has been 4 to 5 days since her symptoms appeared.
Chills, extreme fatigue, swollen hot red rash. An inch below the injections site that started 4 days after the injection and lasted 5 days. Fatigue is ongoing.
Nueropathy (numbness weakness tingling) on right side.  Loss of vision 30 minutes right side.  Headaches, temple pain, sinus pain.  Shots of random pain throughout body.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated that there were two different lot numbers of PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share with Merck. Follow up information has been received from the registered nurse who provided patients' details. This report refers to a 6 weeks old infant patient of unknown gender. On 19-JUN-2014, the patient was vaccinated with a dose of PEDVAXHIB lot number J016188, expiration date: 02-OCT-2016, (dose and route were not reported) that was improperly stored. No adverse effects reported. This is one of several reports received from the same reporter. Additional information is not expected because follow up has been obtained.
About 24 hours post vaccination, pt noticed a swelling at injection site approximately 4-5" diameter. It was hot, red, itchy. Swelling resolved approximately 1 1/2 wks later. As of 10/29/15, it still itches but is not hot. Treating itchiness with hydrocortisone cr. Pt states it looks like a scar,
REDNESS; SWELLING; SORENESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802068, and batch number:  UNKNOWN) dose was not reported, administered on 08-MAR-2021 14:30 for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced soreness. On 09-MAR-2021, the subject experienced redness. On 09-MAR-2021, the subject experienced swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from redness, and swelling on 11-MAR-2021, and was recovering from soreness. This report was non-serious.
Information has been received from a registered nurse concerning a 61 year old patient who was vaccinated with PREVNAR instead of PNEUMOVAX 23.  No symptoms were reported.  At the time of the report the patient's outcome was unknown.  Additional information is not expected.
Fever of 101.6 F., body aches, headache, night sweats, and hot flashes (for a week after the shot and mush worse than normal) with chest tightness.
Patient got Menveo instead of an MMR dose; This case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a female patient who received Men ACWY-CRM NVS (Menveo) for prophylaxis.   On an unknown date, the patient received Menveo. On an unknown date, unknown after receiving Menveo, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The pharmacist reported that, in another facility, the patient received Menveo by mistake dose instead of an MMR dose, which led to wrong vaccine administered.  Then, the patient went to the pharmacy, where this case had been reported to get Boostrix and MMR vaccination.
Day after shot for 1 month I had rashes on my torso . Dizzy and light headed . Blood pressure was very high causing chest pain . Blood pressure would drop and I would pass out . Had brain fog for 2 months . Right arm would go numb off and on for 3 months . Night sweats and terrors lasted about 8 months . Vision in left eye still off after first vaccine . Overall symptoms did not stop until February 2022 . Started within minutes of first shot and got worse after second . After first shot went to clinic with sever chest pain . Doctor stated it was probably an adverse reaction to the ingredients .  Both shots made me far sicker than Covid 19 .
Chills, fever, aches, headache, nausea, vomiting, pain and swelling at injection site.  Took Tylenol in evening of the  12th, once I thought I?d be able to keep pills down and not vomit them back up.
This spontaneous report was received from a registered nurse concerning an unknown number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored dose of PEDVAXHIB, (lot # reported as M027883, expiration date 15-APR-2019) (lot # M010440, expiration date 09-DEC-2018) (lot # M025193, expiration date 21-MAR-2019) (lot # reported as M032149, expiration date 18-APR-2019), (dose number, route and anatomical location of administration were unknown). The temperature excursions reported was 10.7 C for 1.5 hours. There was no previous temperature excursion. The temperature excursion was detected by a digital data logger. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
ALLERGIC REACTION, INIT ALLERGIC REACTION, SUBSEQ 1/19/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
arm/joint pain, vomiting chills low grade fever overnight, headache. Severe pain in shoulders, hips and lower back lasted 3 days. lymph nodes in armpits very sore. headache lasted 2 days. vomiting lasted 8 hrs. fever(99-101) lasted 2 days. had 3 minor breathing incidents which was alleviated by using rescue inhaler(albuterol)  Called in to Health Service and messaged primary care, was advised to take advil, tylenol, lots fluids and get tested for COVID19.
Had a headache at the time of vaccine but the headache -  after the vaccine the pain went to the  bottom part of my my head and down to my shoulder on the opposite arm of where I had the shot- like my shoulder knotted up .The headache lasted from the 17th to right before April 4, 2021.  My shoulder is still stiff on the opposite side of the injection site at this time.  My doctor told me it might be sinus pressure and he put me on some steroids - had a five day dose and I finished them.
sore throat, fever, nausea, vomiting, chest pain after vomiting, cough, fatigue, headache, body aches. starting 12/26/21
Lymph nodes swollen, chills, fatigue, pulsatile tinnitus, tension headaches
swelling of arm p/post exposure rabies treatments in late SEP94;swelling persists;had exposure to bat urine;
1st dose Dec2021, 2nd not yet; shingles; This case was reported by a pharmacist via call center representative and described the occurrence of shingles in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In December 2021, the patient received the 1st dose of Shingrix. On an unknown date, the patient did not receive the 2nd dose of Shingrix. In August 2022, between 7 and 9 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced shingles. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the shingles and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.     Additional Information: GSK Receipt Date: 04-OCT-2022 Reporter's Comments: The reporter was the healthcare professional who was reporting on behalf of a patient.  The patient experienced shingles and had not yet received her second dose of Shingrix. The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Did not show up for the second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTENTIONAL PRODUCT USE ISSUE (Did not show up for the second dose) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Did not show up for the second dose). At the time of the report, INTENTIONAL PRODUCT USE ISSUE (Did not show up for the second dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Reporter informed that patient with given initials was not in their appointment list.
Within minutes of getting her Gardasil vaccine she said, "mom, everything is going black." The ladies at the health dept. helped me get her to a table to lay her down on and told me this was a common reaction to this vaccine.
WIthin 5 minutes of patient receiving J&J covid vaccine, she started to develop a large rash on her arm that was quickly spreading. Patient stated that it was not itchy but hurt. I gave her Children's Allergy Relief 12.5mg/5ml  and gave her 10ml. Within 5 minutes the rash was starting to subside already. Patient was kept an additional 5 minutes and felt fine when she left.